Acorda Therapeutics Inc logo

Acorda Therapeutics Inc

1
OTCPK:ACORQ (USA)   Ordinary Shares
$ 0.25 -0.008 (-3.1%) 10:08 PM EST
At Loss
Market Cap:
$ 311.00K
Enterprise V:
$ 186.88M
Volume:
4.28K
Avg Vol (2M):
90.45K
Trade In:
Volume:
4.28K
At Loss
Avg Vol (2M):
90.45K

Business Description

Acorda Therapeutics Inc logo
Acorda Therapeutics Inc
NAICS : 325414 SIC : 2836
ISIN : US00484M1062

Share Class Description:

ACORQ: Ordinary Shares
Description
Acorda Therapeutics Inc is a biopharmaceutical company engaged in developing therapies that restore function and improve the lives of people with neurological disorders. The company market Inbrija (levodopa inhalation powder), which is approved in the U.S. for intermittent treatment of OFF episodes, also known as OFF periods, in people with Parkinson's disease treated with carbidopa/levodopa. Inbrija is for as-needed use and utilizes the ARCUS pulmonary delivery system, a technology platform designed to deliver medication through inhalation. The company also markets branded Ampyra (dalfampridine) Extended-Release Tablets, 10 mg to improve walking in adults with multiple sclerosis. The company's Net product revenue is derived from the sales of Ampyra and Inbrija.
Name Current Vs Industry Vs History
Cash-To-Debt 0.05
Equity-to-Asset -2.28
Debt-to-Equity -1.06
Debt-to-EBITDA -0.79
Piotroski F-Score 5/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -33.03
Distress
Grey
Safe
Beneish M-Score -3.35
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 22.94
9-Day RSI 28.99
14-Day RSI 28.94
6-1 Month Momentum % -97.21
12-1 Month Momentum % -96.86

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 0.22
Quick Ratio 0.15
Cash Ratio 0.04
Days Inventory 354.31
Days Sales Outstanding 38.53
Days Payable 198.43

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -37.9
Shareholder Yield % -1300.54

Financials (Next Earnings Date:2024-08-30 Est.)

ACORQ's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with OTCPK:ACORQ

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Acorda Therapeutics Inc Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 115.664
EPS (TTM) ($) -212.09
Beta 2.9
Volatility % 130.82
14-Day RSI 28.94
14-Day ATR ($) 0.129801
20-Day SMA ($) 0.4579
12-1 Month Momentum % -96.86
52-Week Range ($) 0.23 - 18.205
Shares Outstanding (Mil) 1.24

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 5
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Acorda Therapeutics Inc Filings

Filing Date Document Date Form
No Filing Data

Acorda Therapeutics Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Acorda Therapeutics Inc Frequently Asked Questions

What is Acorda Therapeutics Inc(ACORQ)'s stock price today?
The current price of ACORQ is $0.25. The 52 week high of ACORQ is $18.20 and 52 week low is $0.23.
When is next earnings date of Acorda Therapeutics Inc(ACORQ)?
The next earnings date of Acorda Therapeutics Inc(ACORQ) is 2024-08-30 Est..
Does Acorda Therapeutics Inc(ACORQ) pay dividends? If so, how much?
Acorda Therapeutics Inc(ACORQ) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1